Table 1.

HRVC-QCE detections, severity of respiratory illness and diagnosis.

Diagnosis and HRVC-QCE variant	Age in months (number and proportion of HRVC-QCE detections)/sex and pre-existing conditions	Other viruses co-detected	Hospital admission	Cough/fever	Severity score
Expiratory wheezing (n = 5; 38.5%)
HRVC-QCE 001	42/Ma		Y	Y/N	2
HRVC-QCE 004	24/Fa,b		Y	Y/Y	1
HRVC-QCE 005	10/Ma	HBoV	Y	Y/N	3
HRVC-QCE 006	18/Ma	HBoV; KIPyV	Y	Y/N	1
HRVC-QCE 007	12/Ma		Y	Y/N	2
Transplant or underlying conditions (n = 5; 38.5%)
HRVC-QCE 003	10/F ALL. Deceasedb		Y	Y/N	3
HRVC-QCE 010	9/F AMLb		Y	N/N	1
HRVC-QCE 009	5/M CFb		Y	Y/N	2
HRVC-QCE 013	26/M CFb	HRSV	N	Y/NR	0
HRVC-QCE 012	7/M Lung disease of prematurity; bronchiolitisa	HBoV	Y	NR/N	1
Febrile convulsion (n = 2; 15.4%)
HRVC-QCE 008	20/Fb		Y	Y/Y	2
HRVC-QCE 011	15/M	HBoV	Y	N/Y	1
Upper respiratory tract infection (n = 1; 7.7%)
HRVC-QCE 002	9/F		N	Y/Y	0

ALL = acute lymphoblastic leukemia; AML = acute myeloblastic leukemia; CF = cystic fibrosis; HBoV = human bocavirus; HRSV = human respiratory syncytial virus; KIPyV = KI polyomavirus; M = male; F = female; NR = not recorded in chart.

^aBronchodilators.

^bAntibiotics.